Carpal Tunnel Syndrome Market Size to Worth USD 1,328.69 Mn by 2032

The global carpal tunnel syndrome market size is calculated at USD 955.99 million in 2024 and is expected to be worth around USD 1,328.69 million by 2032, growing at a CAGR of 3.7% from 2024 to 2032.

Ottawa, May 24, 2024 (GLOBE NEWSWIRE) — The global carpal tunnel syndrome market size was valued at USD 942.69 million in 2023 and is predicted to hit around USD 1,232.21 million by 2031, a study published by Towards Healthcare a sister firm of Precedence Research.

Download the sample report to explore the projected growth of the carpal tunnel syndrome market from 2024 to 2032 @ Get Carpal Tunnel Syndrome Market Sample Report Here

Report Highlights:

  • Integrative therapy reported a significant 38% market share in 2023.
  • NSAIDs were the most popularly used medications in 2023.
  • North America accounted for the dominant 32% market share in 2023.

Doing certain types of work can lead to more cases of Carpal Tunnel Syndrome. The US Department of Labor and Statistics found that for every 10,000 workers, about 0.5 of them develop Carpal Tunnel Syndrome because of their jobs.

90% of all cases of neuropathy are caused by carpal tunnel syndrome, the most common focal mononeuropathy. The entrapment neuropathy that results from compression of the median nerve during its passage through the carpal tunnel causes this condition. Pain, numbness, and feeling paresthesia in the median nerve distribution are the first symptoms of carpal tunnel syndrome. Since most patients with carpal tunnel syndrome experience a progressive condition, improper diagnosis and treatment may lead to a permanent loss of hand function and sensation. This exercise examines the causes, manifestations, assessments, and treatment of carpal tunnel syndrome while emphasizing the interprofessional healthcare team’s cooperative efforts in diagnosing and managing the illness.

Examples of the Risk Factors Associated with Carpal Tunnel Syndrome Include:

  • Osteoporosis
  • Inflammatory arthritis
  • Infectious arthritis
  • Carpal dislocation or subluxation, fractures or skewed consolidation of distal radius
  • Acromegaly
  • Cysts or tumors within the tunnel
  • Pregnancy
  • Menopause
  • Obesity
  • Kidney failure
  • Alcoholism
  • Hypothyroidism
  • Vitamin deficiency
  • Use of oral contraceptives
  • Congestive heart failure
  • Diabetes

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Early diagnosis and treatment of carpal tunnel syndrome is paramount for several reasons. Carpal tunnel syndrome it arises when the median nerve, extending from the forearm into the palm, undergoes compression at the wrist. Timely identification is key in preventing the condition’s progression, as early intervention can effectively halt or slow down the development of symptoms, mitigating the risk of enduring damage.

Swift treatment is designed to alleviate pressure on the median nerve, crucial for preserving its function and maintaining sensory and motor control in the hand and fingers. Addressing carpal tunnel syndrome in its early stages significantly enhances the overall quality of life for patients by alleviating pain, numbness and sensation that might interfere with daily activity.

For individuals employed in the jobs requiring repetitive hand movements, early intervention is instrumental in preserving work abilities. It can minimize the likelihood of surgery being the only viable option for severe cases of carpal tunnel syndrome, thus reducing the need for invasive procedures.

From an economic standpoint, timely diagnosis and treatment play a crucial role in reducing healthcare costs associated with prolonged medical care and potential disability This, in turn, minimizes the economic impact on both affected individuals and society as a whole. Early detection of carpal tunnel syndrome not only alleviates immediate symptoms but also serves as a cornerstone in preserving nerve function.

Customize the report to tailor insights specific to your needs and objectives in the carpal tunnel syndrome market landscape @ Get Customized Carpal Tunnel Syndrome Market Report Here

Repetitive Tasks are Responsible for Carpal Tunnel Syndrome

Repetitive tasks, like typing or assembly line work, can strain the wrist’s median nerve, leading to carpal tunnel syndrome. This condition causes pain, numbness, and tingling in the hand and fingers. With modern jobs relying heavily on computers and repetitive activities, carpal tunnel syndrome prevalence is rising.

  • Carpal Tunnel Syndrome is commonly recognized as the most prevalent form of compressive neuropathy. Within the United States, it has been reported to occur at a rate of 1 to 3 cases per 1,000 individuals annually, with a prevalence of 50 cases per 1,000 people.
  • The US Department of Labor and Statistics states that the occupational occurrence rate of carpal tunnel syndrome is 0.5 cases per 10,000 workers.

The wrist’s carpal tunnel houses the median nerve, and repeated motions can inflame the surrounding tendons, putting pressure on the nerve.

As awareness grows, more people seek medical attention for early diagnosis. Diagnostic advancements, such as nerve conduction tests and ultrasound, aid in accurate identification. An aging population is also a key factor, as carpal tunnel syndrome becomes more common, with age. Non-surgical treatments like wrist splints and physical therapy, are preferred, driving demand for these options. Minimally invasive procedures, like endoscopic release, are gaining popularity due to there effectiveness with shorter recovery times.

New Diagnostic Technologies are Making it Easier to Detect Carpal Tunnel Syndrome Quickly

Modern Advancements in diagnostic technology are making a big difference in how we tackle carpal tunnel syndrome. Thanks to the innovation, we now have more precise and efficient ways to diagnose carpal tunnel syndrome. Nerve induction studies and electromyography are crucial tools that help identify nerve damage and assess how serious the condition is.

One of the best tools for diagnosis of carpal tunnel syndrome is high-resolution gives healthcare professionals a detailed look at the carpal tunnel, making it easier to diagnose carpal tunnel syndrome early and accurately. With these advanced tools, Doctors can create personalized treatment plans based on a deep understanding of each patient’s unique situation.

Findings from an ultrasound for carpal tunnel syndrome: An ultrasound for carpal tunnel syndrome may show multiple anomalies, such as:

  • An Enlarged Median Nerve: Compression of the median nerve in carpal tunnel syndrome may result in its swelling. The median nerve’s size can be determined via ultrasound and compared to typical values.
  • Flexor Retinaculum Thickening: The ligament that forms the carpal tunnel’s roof is called the flexor retinaculum. The thickening of the flexor retinaculum in carpal tunnel syndrome may result in additional compression of the median nerve.
  • Fluid Around the Tendons: carpal tunnel syndrome may occasionally result in the accumulation of fluid around the wrist tendons. This appears as an anechoic area (dark area) on the ultrasound image.

The best part is that these modern diagnostic technologies are not just diagnosis devices they actually make a real impact on patient outcomes. By catching carpal tunnel syndrome early, doctors can intervene promptly. This means patients can receive non-invasive or minimally invasive treatments, which are less of a burden on both the patients and the healthcare systems. The integration of these sophisticated diagnostic technologies not only raises the level of care for people dealing with carpal tunnel syndrome but also contributes to the growth of the carpal tunnel syndrome market.

Affordable Companions for those with Wrist Issues are Shown by Wrist Splints and Braces

Wrist splints and braces are like superheroes for dealing with carpal tunnel syndrome, a common wrist issue causing pain. Imagine them as little protectors- they support your wrist, stop it from moving too much, and ease the pressure on a nerve inside that gets squished in carpal tunnel syndrome.

These wrist splints and braces are especially great during activities that make carpal tunnel syndrome worse, like typing or doing the same hand movement over and over. The cool part? They’re not surgery and expensive treatments- they’re like affordable sidekicks for both people with wrist troubles and doctors.

More and more people are getting to know about carpal tunnel syndrome, especially those working on computers a lot. Think of it like this, as more folks realize the importance of taking care of their wrists, the demand for these helpful wrist supporters is shooting up.  Wrist splints and braces are getting fancy upgrades. They’re becoming super comfy and easy to use, with special ones for day and night. This means they’re like your wrist’s best friend, offering constant relief if you’re dealing with carpal tunnel syndrome.

The Top Wrist Braces of 2024 for Arthritis, Carpal Tunnel Syndrome, Wrist Injuries and Prophylactic Support

  • Featol wrist brace with wrist splint
  • Expoprox gel wrist rest pads
  • Copper compression fingerless arthritis gloves

Doctors often suggest using these wrist helpers along with other changes in your daily life. It’s like a teamwork approach- making little adjustments in what you do and maybe getting some extra help from this wrist gadget. This friendly combo is boosting the popularity of wrist supports, as people want solutions that fit into their lives smoothly.

Lack of Awareness Creates Problems

Carpal tunnel syndrome is often misunderstood, and this occurs due to a lack of awareness creates challenges in the market. Some people might not recognize the symptoms early, leading to delayed diagnosis and treatment. There are misconceptions about available treatments, making it difficult for patients to choose the most effective solutions.

There’s a range of treatments from lifestyle changes to surgical options, and the effectiveness varies for each individual. This uncertainty can discourage people from seeking proper care. To overcome these hurdles, it’s crucial to improve public understanding of carpal tunnel syndrome, ensuring timely diagnosis and promoting informed decisions about treatment options.

Geographical Landscape

In North America, the geographical landscape for carpal tunnel syndrome is characterized by the prevalence of the syndrome. Carpal tunnel syndrome rates vary based on location. Urban areas, with demanding jobs, may see more cases. Access to healthcare differs between urban and rural areas, affecting diagnosis and treatment. Public awareness efforts vary by region. Collaborative efforts among healthcare providers, communities, and workplaces are crucial to addressing carpal tunnel syndrome effectively.

The Asia Pacific region dominates the market of carpal tunnel syndrome. Factors such as varying healthcare infrastructure, cultural attitudes towards healthcare, and differences in occupational patterns contribute to the prevalence and management of carpal tunnel syndrome. In some emerging economies, limited healthcare resources and awareness may lead to underdiagnosis and undertreatment.

Competitive Landscape

There are pharmaceutical companies that produce medications to manage pain and inflammation associated with carpal tunnel syndrome. These may include nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids. Some companies specialize in creating medical devices specifically for carpal tunnel syndrome treatment, such as ergonomic keyboards or computer mice designed to reduce strain on the wrist. In severe cases, surgery may be recommended to relieve pressure on the median nerve. Surgeons and medical facilities that specialize in carpal tunnel syndrome surgery make up another aspect of the competitive landscape. Physical therapy clinics offer exercises and techniques to strengthen the muscles in the hand and wrist, as well as improve flexibility and reduce strain on the median nerve.

Browse More Insights of Towards Healthcare:

  • The global AI in medical coding market size was projected at USD 2.06 billion in 2022 to reach around USD 7.15 billion by 2032, staggering at a CAGR of 13.3% between 2023 and 2032.
  • The global life science tools market size was valued at USD 111.28 billion in 2022 to soar around USD 367.16 billion by 2032, expanding at a CAGR of 13% between 2023 and 2032.
  • The global 5G healthcare market size to grow from USD 41.89 billion in 2022 to reach around USD 266.60 billion by 2032, expanding at a double digit CAGR of 20.82% between 2023 and 2032.
  • The global metaverse in healthcare market size was valued at USD 8.29 billion in 2022 and is projected to hit USD 81.99 billion by 2032, growing at a CAGR of 26.3% between 2023 and 2032.
  • The global health insurance market size was estimated at USD 1.54 trillion in 2022 to hit around USD 3.02 trillion by 2032, growing at a CAGR of 7.4% between 2023 and 2032.
  • The global AI in breast imaging market size to grow from USD 480 million in 2022 to reach around USD 734.24 million by 2032, at a CAGR of 3.30% between 2023 and 2032.
  • The global bionic eye market size was valued at USD 91.98 million in 2022 to reach around USD 199.97 million by 2032, growing at a CAGR of 8.89% from 2023 to 2032.
  • The artificial intelligence (AI) in precision medicine market size is projected to grow from USD 1.74 billion in 2022 to reach around USD 16.91 billion by 2032, registered at a CAGR of 25.54% between 2023 and 2032.
  • The global AI in ultrasound imaging market was valued at USD 881.2 million in 2022 to surpass an estimated USD 2,001.51 million by 2032, expanding at a CAGR of 8.6% between 2023 and 2032.
  • The global antacids market size is estimated to grow from USD 7.00 billion in 2022 to surpass around USD 9.64 billion by 2032, registered at a CAGR of 3.30% between 2023 and 2032.

Recent Developments

  • In April 2022, Sonex Health announced the commercial introduction of its UltraGuideTFR device in the United States. This device is specifically customized for trigger finger release (TFR) procedures and operates alongside real-time ultrasound guidance. The goal of this launch is to offer physicians an effective tool for performing TFR procedures with greater precision.
  • In March 2022, PAVmed Inc. announced a major development in its PortIO Intraosseous Infusion System. Three patients underwent a successful system implant by doctors at Clinica Porto Azul in Barranquilla, Colombia. This clinical study is the company’s first human trial, and the Institutional Review Board (IRB) has approved it. A critical first step in evaluating the efficacy and safety of the PortIO system is this study, which is intended to include up to 40 patients.
  • In January 2021, Stryker completed the acquisition of OrthoSensor, a leading company in the digital transformation of musculoskeletal care and sensor technology for total joint replacement. This acquisition enabled Stryker to enhance its orthopedic division by integrating intelligent devices and data services into its product portfolio.

Carpal Tunnel Syndrome Market Players

  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Novartis AG (Switzerland)
  • Stryker Corporation
  • Smith & Nephew Plc
  • CONMED Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Bristol-Myers Squibb Company

Carpal Tunnel Syndrome Market Segments

By Diagnosis

  • Electrophysiological Tests
  • Imaging Tests

By Treatment

  • Medication
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • Corticosteroid Injections
    • Other Medications
  • Integrative Therapy
    • Wrist Splinting and Bracing
    • Physical Therapy
    • Ergonomics Modifications
    • Other Integrative Therapy
  • Surgery

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America

Acquire our comprehensive analysis today @ https://www.towardshealthcare.com/price/5138

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Browse our Brand-New Journals:

https://www.towardspackaging.com

https://www.towardsautomotive.com 

Web: https://www.precedenceresearch.com

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Get Our Freshly Printed Chronicle: https://www.healthcarewebwire.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy